CathyEngMD
@cathyengmd.bsky.social
Vanderbilt-Ingram Cancer Center, Professor, David H Johnson Endowed Chair In Surg and Med Oncology,
VICC Associate Director, Strategic Relations and Research Partnerships
Co-Director/Co-Leader, GI Oncology Research Program
Exec Direc, YA Cancers Program
VICC Associate Director, Strategic Relations and Research Partnerships
Co-Director/Co-Leader, GI Oncology Research Program
Exec Direc, YA Cancers Program
For newly diagnosed met #pancreas #cancer: The phase III #arcusbiosciences PRISM-1 trial is open:
💠NCT06608927
💠Gem/Nab-paclitaxel +/- Quemlicustat (Q)
💠Based on promising Ib activity
💠Q is a CD73 inhibitor to enhance antitumor immunity
#DrDanaCardinMD @pancan.bsky.social #cancerresearch
💠NCT06608927
💠Gem/Nab-paclitaxel +/- Quemlicustat (Q)
💠Based on promising Ib activity
💠Q is a CD73 inhibitor to enhance antitumor immunity
#DrDanaCardinMD @pancan.bsky.social #cancerresearch
May 23, 2025 at 10:23 PM
For newly diagnosed met #pancreas #cancer: The phase III #arcusbiosciences PRISM-1 trial is open:
💠NCT06608927
💠Gem/Nab-paclitaxel +/- Quemlicustat (Q)
💠Based on promising Ib activity
💠Q is a CD73 inhibitor to enhance antitumor immunity
#DrDanaCardinMD @pancan.bsky.social #cancerresearch
💠NCT06608927
💠Gem/Nab-paclitaxel +/- Quemlicustat (Q)
💠Based on promising Ib activity
💠Q is a CD73 inhibitor to enhance antitumor immunity
#DrDanaCardinMD @pancan.bsky.social #cancerresearch
#colonoscopy completed 👏!
🙏🏻 to the great team at #VanderbiltUnivMedCenter!
Polyps removed so back again in 3 yrs👍
👉It takes 5-10 yrs for a polyp to become cancerous
👉A colonoscopy removes all precancerous polyps.
👉Get screened!!!
#colorectalcancer #cancerprevention
@fightcrc.bsky.social
🙏🏻 to the great team at #VanderbiltUnivMedCenter!
Polyps removed so back again in 3 yrs👍
👉It takes 5-10 yrs for a polyp to become cancerous
👉A colonoscopy removes all precancerous polyps.
👉Get screened!!!
#colorectalcancer #cancerprevention
@fightcrc.bsky.social
May 8, 2025 at 3:45 PM
#colonoscopy completed 👏!
🙏🏻 to the great team at #VanderbiltUnivMedCenter!
Polyps removed so back again in 3 yrs👍
👉It takes 5-10 yrs for a polyp to become cancerous
👉A colonoscopy removes all precancerous polyps.
👉Get screened!!!
#colorectalcancer #cancerprevention
@fightcrc.bsky.social
🙏🏻 to the great team at #VanderbiltUnivMedCenter!
Polyps removed so back again in 3 yrs👍
👉It takes 5-10 yrs for a polyp to become cancerous
👉A colonoscopy removes all precancerous polyps.
👉Get screened!!!
#colorectalcancer #cancerprevention
@fightcrc.bsky.social
You may wonder 🤔 what I am doing on my #cancerresearch non-clinic day besides trying to finish a research paper🤓? Well even #colorectalcancer medical oncologists need to complete their #cancerprevention #screening exams. #colonoscopy prep time! #cancer #crcsm @fightcrc.bsky.social
May 7, 2025 at 4:32 PM
You may wonder 🤔 what I am doing on my #cancerresearch non-clinic day besides trying to finish a research paper🤓? Well even #colorectalcancer medical oncologists need to complete their #cancerprevention #screening exams. #colonoscopy prep time! #cancer #crcsm @fightcrc.bsky.social
Reposted by CathyEngMD
Wanted to share our April #YoungAdult with #cancer newsletter. Our data coordinator, Amala, has done an amazing job! 🤩 👏👏
Link: bit.ly/447PUVA
PLS utilize some of our resources.
#cancer #cancerresearch @FightCRC #Vanderbilt-IngramCancerCenter
Link: bit.ly/447PUVA
PLS utilize some of our resources.
#cancer #cancerresearch @FightCRC #Vanderbilt-IngramCancerCenter
April 28, 2025 at 4:46 PM
Wanted to share our April #YoungAdult with #cancer newsletter. Our data coordinator, Amala, has done an amazing job! 🤩 👏👏
Link: bit.ly/447PUVA
PLS utilize some of our resources.
#cancer #cancerresearch @FightCRC #Vanderbilt-IngramCancerCenter
Link: bit.ly/447PUVA
PLS utilize some of our resources.
#cancer #cancerresearch @FightCRC #Vanderbilt-IngramCancerCenter
Reposted by CathyEngMD
Wanted to share our April #YoungAdult with #cancer newsletter. Our data coordinator, Amala, has done an amazing job! 🤩 👏👏
Link: bit.ly/447PUVA
PLS utilize some of our resources.
#cancer #cancerresearch @FightCRC #Vanderbilt-IngramCancerCenter
Link: bit.ly/447PUVA
PLS utilize some of our resources.
#cancer #cancerresearch @FightCRC #Vanderbilt-IngramCancerCenter
April 28, 2025 at 4:46 PM
Wanted to share our April #YoungAdult with #cancer newsletter. Our data coordinator, Amala, has done an amazing job! 🤩 👏👏
Link: bit.ly/447PUVA
PLS utilize some of our resources.
#cancer #cancerresearch @FightCRC #Vanderbilt-IngramCancerCenter
Link: bit.ly/447PUVA
PLS utilize some of our resources.
#cancer #cancerresearch @FightCRC #Vanderbilt-IngramCancerCenter
What an incredibly rewarding day! 🙏🏻 #NFLAlumniAssociation #CDC #omegapsiphi for #GearUpAgainstCancer #colorectal #cancer campaign. #Tennessee is one of the 1st states. TY for sharing these very personal stories. SO IMPACTFUL! #cancerprevention #getscreened #PayItForward #crcsm #cancerresearch
April 26, 2025 at 11:37 PM
What an incredibly rewarding day! 🙏🏻 #NFLAlumniAssociation #CDC #omegapsiphi for #GearUpAgainstCancer #colorectal #cancer campaign. #Tennessee is one of the 1st states. TY for sharing these very personal stories. SO IMPACTFUL! #cancerprevention #getscreened #PayItForward #crcsm #cancerresearch
@fightcrc.bsky.social was in #Nashville for their Dinner for Champions. So glad to be part of this amazing group to advocate for #colorectalcancer #awareness, #cancerprevention and #treatment. Luv 💙 this new message and hat! More work to be done!! 💪 #cancer #cancerresearch
April 25, 2025 at 12:49 AM
@fightcrc.bsky.social was in #Nashville for their Dinner for Champions. So glad to be part of this amazing group to advocate for #colorectalcancer #awareness, #cancerprevention and #treatment. Luv 💙 this new message and hat! More work to be done!! 💪 #cancer #cancerresearch
Imp article: #Cancer related thrombosis.
✅ 2.5 mg PO BID Apixaban = 5.0 mg po BID x 12M for primary endpoint of recurrent thrombosis. #cancer #cancerresearch #NEJM
✅ 2.5 mg PO BID Apixaban = 5.0 mg po BID x 12M for primary endpoint of recurrent thrombosis. #cancer #cancerresearch #NEJM
April 13, 2025 at 6:43 PM
Imp article: #Cancer related thrombosis.
✅ 2.5 mg PO BID Apixaban = 5.0 mg po BID x 12M for primary endpoint of recurrent thrombosis. #cancer #cancerresearch #NEJM
✅ 2.5 mg PO BID Apixaban = 5.0 mg po BID x 12M for primary endpoint of recurrent thrombosis. #cancer #cancerresearch #NEJM
FDA ☑️ Nivo/Ipi in Unresectable/Metastatic #HCC
☑️OS 23.7M vs. 20.6M vs lenvatinib or sorafenib (HR, 0.79; 95% CI, 0.65-0.96; P = .018).
@FDAOncology @EAHPBA #immunotherapy @bristolmyerssquibb.bsky.social #cancer #CancerResearch #Checkmate9DW
☑️OS 23.7M vs. 20.6M vs lenvatinib or sorafenib (HR, 0.79; 95% CI, 0.65-0.96; P = .018).
@FDAOncology @EAHPBA #immunotherapy @bristolmyerssquibb.bsky.social #cancer #CancerResearch #Checkmate9DW
April 12, 2025 at 4:20 PM
FDA ☑️ Nivo/Ipi in Unresectable/Metastatic #HCC
☑️OS 23.7M vs. 20.6M vs lenvatinib or sorafenib (HR, 0.79; 95% CI, 0.65-0.96; P = .018).
@FDAOncology @EAHPBA #immunotherapy @bristolmyerssquibb.bsky.social #cancer #CancerResearch #Checkmate9DW
☑️OS 23.7M vs. 20.6M vs lenvatinib or sorafenib (HR, 0.79; 95% CI, 0.65-0.96; P = .018).
@FDAOncology @EAHPBA #immunotherapy @bristolmyerssquibb.bsky.social #cancer #CancerResearch #Checkmate9DW
Happened this week: @FDA approves Nivo/Ipi vs. Nivo alone for #MSIhigh or #dMMR met #colorectal #cancer #Checkmate8HW
☑️Median PFS was NR in the combo arm vs. 39.3M (HR = 0.62 [95% CI: 0.48, 0.81]
☑️ORR = 71% vs. 58% (p-value 0.0011)
#CancerResearch #immunotherapy @bristolmyerssquibb.bsky.social
☑️Median PFS was NR in the combo arm vs. 39.3M (HR = 0.62 [95% CI: 0.48, 0.81]
☑️ORR = 71% vs. 58% (p-value 0.0011)
#CancerResearch #immunotherapy @bristolmyerssquibb.bsky.social
April 12, 2025 at 4:17 PM
Happened this week: @FDA approves Nivo/Ipi vs. Nivo alone for #MSIhigh or #dMMR met #colorectal #cancer #Checkmate8HW
☑️Median PFS was NR in the combo arm vs. 39.3M (HR = 0.62 [95% CI: 0.48, 0.81]
☑️ORR = 71% vs. 58% (p-value 0.0011)
#CancerResearch #immunotherapy @bristolmyerssquibb.bsky.social
☑️Median PFS was NR in the combo arm vs. 39.3M (HR = 0.62 [95% CI: 0.48, 0.81]
☑️ORR = 71% vs. 58% (p-value 0.0011)
#CancerResearch #immunotherapy @bristolmyerssquibb.bsky.social
🙏 to #Brazilian #GI Tumors Group #GTG for the invitation to speak at their annual meeting. Honored to speak on #immunotherapy in #colorectalcancer but also the GLOBAL concern of #earlyonset #crc and the need for #education and #awareness. 🙏 Dr R Riechelmann #CancerResearch #cancer #prevention
April 11, 2025 at 5:46 PM
🙏 to #Brazilian #GI Tumors Group #GTG for the invitation to speak at their annual meeting. Honored to speak on #immunotherapy in #colorectalcancer but also the GLOBAL concern of #earlyonset #crc and the need for #education and #awareness. 🙏 Dr R Riechelmann #CancerResearch #cancer #prevention
So delighted to work with 🤩Jeneth Aquino, our amazing GI clinic APP who represents #VanderbiltUniversityMedicalCenter #Nashville Chapter at the annual #OncologyNursingSociety meeting. She’s an amazing colleague!! #cancer #PatientCare #CancerResearch
April 10, 2025 at 2:13 PM
So delighted to work with 🤩Jeneth Aquino, our amazing GI clinic APP who represents #VanderbiltUniversityMedicalCenter #Nashville Chapter at the annual #OncologyNursingSociety meeting. She’s an amazing colleague!! #cancer #PatientCare #CancerResearch
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer: safety analysis of FRESCO-2 academic.oup.com/oncolo/article…#cancere#CancerResearchc#treatmentoptionsn#patientcarer#colorectalcancere#cancerresearchch @adasarimd
https://academic.oup.com/oncolo/article…
April 3, 2025 at 6:20 PM
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer: safety analysis of FRESCO-2 academic.oup.com/oncolo/article…#cancere#CancerResearchc#treatmentoptionsn#patientcarer#colorectalcancere#cancerresearchch @adasarimd
Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute… pubmed.ncbi.nlm.nih.gov/40048671/
Glad to see this finally come out from the #NCI #NCTN @eaonc @SWOG @ALLIANCE_org @NRGonc co-authors! #ctDNA #CancerResearch #Cancer
Glad to see this finally come out from the #NCI #NCTN @eaonc @SWOG @ALLIANCE_org @NRGonc co-authors! #ctDNA #CancerResearch #Cancer
Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute GI Oncology Circulating Tumor DNA Working Group - PubMed
Prospective trials are required to clarify the role of ctDNA as a valid surrogate end point for progression-free or overall survival in GI cancers.
pubmed.ncbi.nlm.nih.gov
April 1, 2025 at 12:53 PM
Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute… pubmed.ncbi.nlm.nih.gov/40048671/
Glad to see this finally come out from the #NCI #NCTN @eaonc @SWOG @ALLIANCE_org @NRGonc co-authors! #ctDNA #CancerResearch #Cancer
Glad to see this finally come out from the #NCI #NCTN @eaonc @SWOG @ALLIANCE_org @NRGonc co-authors! #ctDNA #CancerResearch #Cancer
Happy #DoctorsDay to ALL my colleagues for all your hard work, diligence, collegiality and friendship! #cancer #cancerresearch #academia #grateful 🙏
March 30, 2025 at 2:47 PM
Happy #DoctorsDay to ALL my colleagues for all your hard work, diligence, collegiality and friendship! #cancer #cancerresearch #academia #grateful 🙏
Reposted by CathyEngMD
Not your average GI oncology photo op at #GDST.
Our co-chairs, Dr. Yelena Janjigian and Dr. @cathyengmd.bsky.social, not just leading the GI track—making the whole place shimmer! Leading important conversations and repping a little #Swiftie spirit.
#MedicalEducation #CancerCare #GreatDebates
Our co-chairs, Dr. Yelena Janjigian and Dr. @cathyengmd.bsky.social, not just leading the GI track—making the whole place shimmer! Leading important conversations and repping a little #Swiftie spirit.
#MedicalEducation #CancerCare #GreatDebates
March 23, 2025 at 4:48 PM
Not your average GI oncology photo op at #GDST.
Our co-chairs, Dr. Yelena Janjigian and Dr. @cathyengmd.bsky.social, not just leading the GI track—making the whole place shimmer! Leading important conversations and repping a little #Swiftie spirit.
#MedicalEducation #CancerCare #GreatDebates
Our co-chairs, Dr. Yelena Janjigian and Dr. @cathyengmd.bsky.social, not just leading the GI track—making the whole place shimmer! Leading important conversations and repping a little #Swiftie spirit.
#MedicalEducation #CancerCare #GreatDebates
Always a pleasure to chair a meeting with Dr. Yelena Janjigian! Please join us for our 1st combined solid tumor hybrid meeting:
Great Debates in Solid Tumors.
@greatdebates.bsky.social
Register: hmpglobalevents.com/gdst/agenda
🤩@NVijayvergiaMD #NET at 10AM today. #Cancer #cancerresearch
Great Debates in Solid Tumors.
@greatdebates.bsky.social
Register: hmpglobalevents.com/gdst/agenda
🤩@NVijayvergiaMD #NET at 10AM today. #Cancer #cancerresearch
March 22, 2025 at 11:22 AM
Always a pleasure to chair a meeting with Dr. Yelena Janjigian! Please join us for our 1st combined solid tumor hybrid meeting:
Great Debates in Solid Tumors.
@greatdebates.bsky.social
Register: hmpglobalevents.com/gdst/agenda
🤩@NVijayvergiaMD #NET at 10AM today. #Cancer #cancerresearch
Great Debates in Solid Tumors.
@greatdebates.bsky.social
Register: hmpglobalevents.com/gdst/agenda
🤩@NVijayvergiaMD #NET at 10AM today. #Cancer #cancerresearch
We are SO EXCITED to share our updated monthly @VUMC_Cancer #YoungAdultCancer Program Newsletter! 👏👏👏
For ALL young adults 20-50 y/o with #cancer.
Newsletter Link: shorturl.at/t7p7F
#patientcare #tooyoung #AYA #unmetneeds
@vumc-insights.bsky.social #CancerResearch
For ALL young adults 20-50 y/o with #cancer.
Newsletter Link: shorturl.at/t7p7F
#patientcare #tooyoung #AYA #unmetneeds
@vumc-insights.bsky.social #CancerResearch
March 20, 2025 at 5:56 PM
We are SO EXCITED to share our updated monthly @VUMC_Cancer #YoungAdultCancer Program Newsletter! 👏👏👏
For ALL young adults 20-50 y/o with #cancer.
Newsletter Link: shorturl.at/t7p7F
#patientcare #tooyoung #AYA #unmetneeds
@vumc-insights.bsky.social #CancerResearch
For ALL young adults 20-50 y/o with #cancer.
Newsletter Link: shorturl.at/t7p7F
#patientcare #tooyoung #AYA #unmetneeds
@vumc-insights.bsky.social #CancerResearch
Looking forward to giving this #patient forum next Wed for #ColorectalCancerAwarenessMonth #colorectal #cancer and introducing our new #earlyonset #youngadult cancers Program Manager. #patientcare #advocacy #CancerResearch @vumc-insights.bsky.social @fightcrc.bsky.social #crcsm
March 20, 2025 at 12:09 PM
Looking forward to giving this #patient forum next Wed for #ColorectalCancerAwarenessMonth #colorectal #cancer and introducing our new #earlyonset #youngadult cancers Program Manager. #patientcare #advocacy #CancerResearch @vumc-insights.bsky.social @fightcrc.bsky.social #crcsm
CORRECT Link -
2025 Fast Facts:
🔷154,270 will be diagnosed
🔷 19,330 patients < 50 y/o
We created a video using
discussing the benefit of #colorectalcancer #cancerprevention. embed.vidyard.com/share/n8etur...
#ColorectalCancerAwarenessMonth
#cancer #crcsm
@FightCRC
@OncoAlert
@VUMC_Cancer
2025 Fast Facts:
🔷154,270 will be diagnosed
🔷 19,330 patients < 50 y/o
We created a video using
discussing the benefit of #colorectalcancer #cancerprevention. embed.vidyard.com/share/n8etur...
#ColorectalCancerAwarenessMonth
#cancer #crcsm
@FightCRC
@OncoAlert
@VUMC_Cancer
Getting a Colonoscopy: Who, why and when
Knowing the signs and symptoms when you need to get a colonoscopy, describing prep and procedure, and importance of getting screened.
© Vanderbilt University Medical Center
embed.vidyard.com
March 15, 2025 at 9:35 AM
CORRECT Link -
2025 Fast Facts:
🔷154,270 will be diagnosed
🔷 19,330 patients < 50 y/o
We created a video using
discussing the benefit of #colorectalcancer #cancerprevention. embed.vidyard.com/share/n8etur...
#ColorectalCancerAwarenessMonth
#cancer #crcsm
@FightCRC
@OncoAlert
@VUMC_Cancer
2025 Fast Facts:
🔷154,270 will be diagnosed
🔷 19,330 patients < 50 y/o
We created a video using
discussing the benefit of #colorectalcancer #cancerprevention. embed.vidyard.com/share/n8etur...
#ColorectalCancerAwarenessMonth
#cancer #crcsm
@FightCRC
@OncoAlert
@VUMC_Cancer
🙏 @fightcrc.bsky.social for making our mission to promote #ColorectalCancerAwarenessMonth #education #prevention #healthcarepolicy so meaningful for #patients and providers. #cancer #CancerResearch #crcsm @vumc-insights.bsky.social
March 12, 2025 at 10:36 AM
🙏 @fightcrc.bsky.social for making our mission to promote #ColorectalCancerAwarenessMonth #education #prevention #healthcarepolicy so meaningful for #patients and providers. #cancer #CancerResearch #crcsm @vumc-insights.bsky.social
I learned this at @FightCRC the small request of $20M for CDMRP #colorectalcancer #cancerresearch. #CRC ranks the lowest! Why are we the high incidence/high mortality CA with NO congressional directed medical research program (CDMRP) funding? I would rather #cancerprevention than treat. @oncoalert
March 11, 2025 at 6:05 PM
I learned this at @FightCRC the small request of $20M for CDMRP #colorectalcancer #cancerresearch. #CRC ranks the lowest! Why are we the high incidence/high mortality CA with NO congressional directed medical research program (CDMRP) funding? I would rather #cancerprevention than treat. @oncoalert
Colleagues, this is a VERY imp message. Pls reach out to your Congress to avoid a 57% reduction ($850M) in Congressionally Directed Medical Research Program (CDMRP) funding for #cancerresearch They are possibly voting tomorrow AM. #cancer #crcsm fightcolorectalcancer.org/advocacy/pub... @fightCRC
Advocacy Action Center
Tell your Members of Congress to protect colorectal cancer research!
fightcolorectalcancer.org
March 10, 2025 at 3:47 PM
Colleagues, this is a VERY imp message. Pls reach out to your Congress to avoid a 57% reduction ($850M) in Congressionally Directed Medical Research Program (CDMRP) funding for #cancerresearch They are possibly voting tomorrow AM. #cancer #crcsm fightcolorectalcancer.org/advocacy/pub... @fightCRC
What a TRULY special day!! 💪💙What a great way to HONOR beloved patients, #cancerprevention and #cancerscreening. #Fightformoretime @fightcrc.bsky.social #prioritizeCRC #strongarmselfie #crcsm #cancer #patientadvocacy @vumc-insights.bsky.social
March 9, 2025 at 9:44 PM
What a TRULY special day!! 💪💙What a great way to HONOR beloved patients, #cancerprevention and #cancerscreening. #Fightformoretime @fightcrc.bsky.social #prioritizeCRC #strongarmselfie #crcsm #cancer #patientadvocacy @vumc-insights.bsky.social